Otsuka Europe Development and Commercialisation Ltd.
London Office
West of London Office
Otsuka Europe Development and Commercialisation Ltd. (OEDC) was established in 2013 as Otsuka’s European Research and Development central office. OEDC focuses on clinical strategy, regulatory affairs, pharmacovigilence, global quality management and data and document management. OEDC and Otsuka Pharmaceutical Europe Ltd. (OPEL) work alongside one another to ensure the successful development and commercialisation of our products in Europe. Although they are separate entities, OEDC and OPEL are based in the same location, just outside London (OEDC also has a branch office in Frankfurt). This business model allows for optimal collaboration and is a critical success factor in the evolution of our global business.
OEDC and OPEL are separate entities based in the same location, just outside London (OEDC also has a branch office in Frankfurt). This business model allows for optimal collaboration and is a critical success factor in the evolution of our global business. Our teams work closely together, with aligned goals, to build one integrated European company enabling us to effectively respond to the increasingly rigorous regulatory environment.
phillipe

Philippe Auby

CEO & President, OEDC